Strategic Wealth Partners Ltd. cut its position in shares of Cooper Companies Inc (NYSE:COO) by 12.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 337 shares of the medical device company’s stock after selling 50 shares during the period. Strategic Wealth Partners Ltd.’s holdings in Cooper Companies were worth $113,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Flagship Harbor Advisors LLC raised its stake in Cooper Companies by 62.5% during the second quarter. Flagship Harbor Advisors LLC now owns 78 shares of the medical device company’s stock worth $26,000 after purchasing an additional 30 shares during the period. Evolution Wealth Advisors LLC purchased a new position in Cooper Companies during the second quarter worth about $34,000. Whittier Trust Co. purchased a new position in Cooper Companies during the second quarter worth about $53,000. Ibex Wealth Advisors purchased a new position in Cooper Companies during the second quarter worth about $52,000. Finally, Quadrant Capital Group LLC raised its stake in Cooper Companies by 827.8% during the first quarter. Quadrant Capital Group LLC now owns 167 shares of the medical device company’s stock worth $47,000 after purchasing an additional 149 shares during the period. 96.59% of the stock is currently owned by institutional investors.
Shares of Cooper Companies stock traded down $8.15 on Friday, reaching $321.67. The company had a trading volume of 243,461 shares, compared to its average volume of 251,564. The firm’s 50 day moving average price is $333.71 and its two-hundred day moving average price is $306.05. The firm has a market cap of $16.32 billion, a PE ratio of 27.97, a PEG ratio of 2.50 and a beta of 0.90. Cooper Companies Inc has a 52-week low of $228.65 and a 52-week high of $344.32. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.68 and a current ratio of 1.21.
The firm also recently disclosed a Semi-Annual dividend, which was paid on Wednesday, August 7th. Investors of record on Tuesday, July 23rd were issued a $0.03 dividend. The ex-dividend date was Monday, July 22nd. Cooper Companies’s dividend payout ratio (DPR) is currently 0.52%.
A number of brokerages have commented on COO. Piper Jaffray Companies lifted their target price on shares of Cooper Companies from $330.00 to $360.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 13th. Northcoast Research reissued a “buy” rating and issued a $340.00 price target (up from $331.00) on shares of Cooper Companies in a research note on Monday, June 3rd. KeyCorp boosted their price target on shares of Cooper Companies from $314.00 to $351.00 and gave the company an “overweight” rating in a research note on Thursday. Wells Fargo & Co boosted their price target on shares of Cooper Companies from $356.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Finally, Raymond James boosted their price target on shares of Cooper Companies from $325.00 to $364.00 and gave the company an “outperform” rating in a research note on Tuesday, July 2nd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have issued a buy rating to the company. Cooper Companies has a consensus rating of “Buy” and a consensus target price of $326.27.
In related news, COO Daniel G. Mcbride sold 11,981 shares of Cooper Companies stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $315.99, for a total value of $3,785,876.19. Following the completion of the transaction, the chief operating officer now owns 42,668 shares in the company, valued at $13,482,661.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert S. Weiss sold 52,156 shares of Cooper Companies stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $323.74, for a total transaction of $16,884,983.44. Following the completion of the transaction, the director now owns 154,975 shares of the company’s stock, valued at approximately $50,171,606.50. The disclosure for this sale can be found here. Insiders sold 77,678 shares of company stock valued at $25,063,536 in the last 90 days. Company insiders own 1.70% of the company’s stock.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Story: What is a balanced fund?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.